Facilitation of striatal potassium-induced dopamine release - novel structural requirements for a presynaptic action of benzodiazepines.
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001569:Benzodiazepines; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004357:Drug Synergism; D066298:In Vitro Techniques; D011188:Potassium / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D013569:Synapses / Q000187:drug effects*
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D011188:Potassium; D004298:Dopamine